Depression and Sexual Stigma Are Associated With Cardiometabolic Risk Among Sexual and Gender Minorities Living With HIV in Nigeria.

Sylvia B Adebajo, Ruxton Adebiyi, John Chama, Segun Bello, Uche Ononaku, Abayomi Aka, Shenghan Lai, Stefan D Baral, Typhanye V Dyer, Trevor A Crowell, Rebecca G Nowak, Man Charurat, TRUST/RV368 Study Group
Author Information
  1. Sylvia B Adebajo: Center for International Health Education Biosecurity, University of Maryland Baltimore, Abuja, Nigeria. ORCID
  2. Ruxton Adebiyi: Center for International Health Education Biosecurity, University of Maryland Baltimore, Abuja, Nigeria.
  3. John Chama: Center for International Health Education Biosecurity, University of Maryland Baltimore, Abuja, Nigeria.
  4. Segun Bello: Center for International Health Education Biosecurity, University of Maryland Baltimore, Abuja, Nigeria.
  5. Uche Ononaku: Institute of Human Virology, Abuja, Nigeria.
  6. Abayomi Aka: International Centre for Advocacy on Right to Health-ICARH, Abuja, Nigeria.
  7. Shenghan Lai: Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.
  8. Stefan D Baral: Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  9. Typhanye V Dyer: University of Maryland School of Public Health, College Park, MD.
  10. Trevor A Crowell: Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD.
  11. Rebecca G Nowak: Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.
  12. Man Charurat: Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.

Abstract

BACKGROUND: People living with HIV are vulnerable to cardiometabolic diseases. We assessed the prevalence of cardiometabolic risk factors (CMRF) and associations with sexual stigma and depression among sexual and gender minorities (SGM) in Abuja and Lagos, Nigeria.
METHODS: The TRUST/RV368 study enrolled SGM between March 2013 and February 2020. Participants were assessed for depression, sexual stigma, and CMRF. Robust multinomial logistic regression was used to estimate adjusted odds ratio (aORs) and 95% confidence intervals (CIs) for associations of depression, sexual stigma, and other factors with increasing numbers of CMRF.
RESULTS: Among 761 SGM, the mean age was 25.0 ± 6.0 years; 580 (76%) identified as cisgender men, 641 (84%) had ≥1 CMRF, 355 (47%) had mild-severe depression, and 405 (53%) reported moderate-high sexual stigma. Compared with individuals without depression, those with mild (aOR 8.28; 95% CI: 4.18 to 16.40) or moderate-severe depression (aOR 41.69; 95% CI: 9.60 to 181.04) were more likely to have 3-5 CMRF. Individuals with medium (aOR 3.17; 95% CI: 1.79 to 5.61) and high sexual stigma (aOR 14.42; 95% CI: 2.88 to 72.29) compared with those with low sexual stigma were more likely to have 3-5 CMRF. Participants age 25-34 years were less likely to have 3-5 CMRF (aOR 0.41; 95% CI: 0.23 to 0.73) compared with participants age younger than 25 years.
CONCLUSION: CMRF increased with severity of depression and sexual stigma, potentially predisposing SGM living with HIV to cardiometabolic diseases. Integrating interventions that address depression and sexual stigma in HIV care programs for SGM may improve cardiometabolic outcomes.

References

  1. Am Fam Physician. 2019 Jul 15;100(2):72-73 [PMID: 31305052]
  2. Sex Transm Infect. 2016 Jun;92(4):292-8 [PMID: 26424712]
  3. Circulation. 1999 Apr 27;99(16):2192-217 [PMID: 10217662]
  4. Psychiatry Res. 2020 Jan 21;285:112802 [PMID: 32036152]
  5. BMC Med. 2018 Aug 15;16(1):123 [PMID: 30107800]
  6. Diabetol Metab Syndr. 2014 Aug 25;6(1):92 [PMID: 25197324]
  7. Asian J Psychiatr. 2021 Apr;58:102601 [PMID: 33611083]
  8. Circulation. 2005 Oct 25;112(17):2735-52 [PMID: 16157765]
  9. J Affect Disord. 2015 Mar 15;174:516-21 [PMID: 25554997]
  10. Immunity. 2013 Oct 17;39(4):633-45 [PMID: 24138880]
  11. J Affect Disord. 2020 Dec 1;277:192-203 [PMID: 32829195]
  12. BMJ. 2019 Apr 9;365:l1476 [PMID: 30967483]
  13. AIDS. 2015 Dec;29 Suppl 3:S251-9 [PMID: 26562814]
  14. Psychol Med. 2022 Oct;52(14):3007-3017 [PMID: 33431106]
  15. Indian J Pharmacol. 2012 Mar;44(2):155-6 [PMID: 22529466]
  16. PLoS One. 2013;8(3):e59551 [PMID: 23555704]
  17. Lancet HIV. 2017 Aug;4(8):e349-e356 [PMID: 28501495]
  18. Diabetes Metab Syndr. 2015 Jul-Sep;9(3):183-91 [PMID: 25470634]
  19. Front Neurosci. 2021 May 19;15:619171 [PMID: 34093107]
  20. AIDS. 2017 Nov 13;31(17):2415-2420 [PMID: 28926403]
  21. Shanghai Arch Psychiatry. 2013 Apr;25(2):68-9 [PMID: 24991137]
  22. Obesity (Silver Spring). 2014 Sep;22(9):1959-61 [PMID: 24828961]
  23. Sex Transm Dis. 2016 Apr;43(4):243-8 [PMID: 26967301]
  24. Expert Rev Clin Pharmacol. 2009 Jul;2(4):381-90 [PMID: 22112182]
  25. BMJ Open. 2016 Jul 13;6(7):e011453 [PMID: 27412106]
  26. PLoS One. 2016 Oct 20;11(10):e0164634 [PMID: 27764128]
  27. PLoS One. 2018 Jun 21;13(6):e0199602 [PMID: 29928044]
  28. AIDS Care. 2014;26(7):882-9 [PMID: 24295155]
  29. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):444-453 [PMID: 30550487]
  30. Health Psychol. 2014 Jan;33(1):20-34 [PMID: 24417692]
  31. J Int AIDS Soc. 2017 Apr 20;20(1):21489 [PMID: 28453241]
  32. Hypertension. 2003 Dec;42(6):1206-52 [PMID: 14656957]
  33. AIDS. 2018 Jul 1;32 Suppl 1:S5-S20 [PMID: 29952786]
  34. Diabetologia. 2020 Jul;63(7):1305-1311 [PMID: 32270255]
  35. Clin Infect Dis. 2019 Aug 1;69(4):639-647 [PMID: 30476001]
  36. AIDS Behav. 2018 May;22(5):1662-1670 [PMID: 29168069]
  37. BMC Health Serv Res. 2010 Mar 19;10:71 [PMID: 20302648]
  38. AIDS Behav. 2018 Dec;22(12):3905-3915 [PMID: 29956115]
  39. J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S114-23 [PMID: 25723975]
  40. J Int AIDS Soc. 2016 Dec 07;19(1):21270 [PMID: 27931519]
  41. Int J Epidemiol. 2013 Dec;42(6):1754-71 [PMID: 24415610]
  42. Circulation. 2004 Jan 27;109(3):433-8 [PMID: 14744958]
  43. BMJ. 2009 Jan 26;338:a3172 [PMID: 19171560]
  44. Circ Res. 2020 Nov 6;127(11):1365-1380 [PMID: 32998637]
  45. Psychol Sci. 2017 Jul;28(7):872-881 [PMID: 28504919]
  46. Obes Res Clin Pract. 2018 Jul - Aug;12(4):372-377 [PMID: 28094226]
  47. Curr Hypertens Rep. 2003 Oct;5(5):393-401 [PMID: 12948432]
  48. Curr HIV/AIDS Rep. 2020 Aug;17(4):290-300 [PMID: 32557117]
  49. PLoS One. 2018 Jul 30;13(7):e0201404 [PMID: 30059546]
  50. Clin Infect Dis. 2012 Jul;55(1):126-36 [PMID: 22534147]
  51. Diabet Med. 1998 Jul;15(7):539-53 [PMID: 9686693]
  52. AIDS Care. 2015;27(1):63-70 [PMID: 25162483]
  53. Public Health. 2015 May;129(5):413-23 [PMID: 25736900]
  54. Psychol Med. 2017 Aug;47(11):1867-1879 [PMID: 28196549]
  55. J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S107-13 [PMID: 25723974]
  56. Sci Rep. 2017 Aug 15;7(1):8159 [PMID: 28811618]
  57. J Am Heart Assoc. 2022 Dec 20;11(24):e027610 [PMID: 36533593]
  58. Cardiovasc J Afr. 2010 Jan-Feb;21(1):26-31 [PMID: 20224842]

Grants

  1. R01 MH099001/NIMH NIH HHS
  2. R01 MH110358/NIMH NIH HHS
  3. K07 CA225403/NCI NIH HHS
  4. R01 AI120913/NIAID NIH HHS
  5. /PEPFAR
  6. R01 HL165686/NHLBI NIH HHS
  7. D43 TW010051/FIC NIH HHS

MeSH Term

Humans
Young Adult
Adult
Nigeria
HIV Infections
Sexual and Gender Minorities

Word Cloud

Created with Highcharts 10.0.0sexualCMRFstigmadepression95%SGM0aORCI:HIVcardiometabolicageyearslikely3-5livingdiseasesassessedfactorsassociationsNigeriaParticipantsAmong2541comparedSexualBACKGROUND:PeoplevulnerableprevalenceriskamonggenderminoritiesAbujaLagosMETHODS:TRUST/RV368studyenrolledMarch2013February2020RobustmultinomiallogisticregressionusedestimateadjustedoddsratioaORsconfidenceintervalsCIsincreasingnumbersRESULTS:761mean±658076%identifiedcisgendermen64184%≥135547%mild-severe40553%reportedmoderate-highComparedindividualswithoutmild8284181640moderate-severe6996018104Individualsmedium317179561high14422887229low25-34less2373participantsyoungerCONCLUSION:increasedseveritypotentiallypredisposingIntegratinginterventionsaddresscareprogramsmayimproveoutcomesDepressionStigmaAssociatedCardiometabolicRiskGenderMinoritiesLiving

Similar Articles

Cited By